Guide

GHRH analogues

Built from index records dated 2026-10-09 Compiled by an automated pipeline, checked by The Peptide Observer editorial desk How this site works

GHRH analogues is a group of 3 entries in this index, of which this site describes 1 and holds 2 back pending review.

Only the described entries are counted anywhere on this page.

What this group is

This group holds 3 entries, and every one of them carries a receptor or a pathway named in its records.

Every one of them points at the same place: GHRH receptor. A shared target is what holds this group together.

GHRH receptor

Named in the records of 3 of the 3 entries in this group.

The entries described here

Sermorelin

12 records kept: 12 not stated. None of the records kept here state what kind of study they are.

Publication years of all 12 records kept for the described entries in this group. Oldest 2006, newest 2026. An old record is not a worse record, but a group whose marks all sit to the left has not been looked at recently.

What is held back

2 entries in this group are built and then held back, because publishing them without a qualified reviewer would risk being read as medical guidance. They are: Tesamorelin and CJC-1295. This page says nothing about what their records contain. Why entries are held back.

What is not known

Whether the members of this group have anything in common beyond what the counts above show. A shared receptor is a shared target, not a shared result.
What any of these entries does in a body. Nothing on this site has been read in full, and no record here has been appraised by anyone qualified to appraise it.
Anything at all about the held-back entries named above, beyond the fact that they exist and are being withheld.

Where this comes from

This page reprints no wording from the underlying index. These are the published records that index cites for the existence of this group, listed so the grouping can be checked rather than taken on trust.

Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog. Endocrinology (2005). pmid:15817669
Structural requirements for the activation of rat anterior pituitary adenylate cyclase by growth hormone-releasing factor (GRF): discovery of (N-Ac-Tyr1, D-Arg2)-GRF(1-29)-NH2 as a GRF antagonist on membranes. Endocrinology (1985). pmid:2994998
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab (2006). pmid:16352683